The present invention relates to compounds, compositions thereof and methods to selectively treat fungal infections. More particularly, this invention relates to compounds, compositions thereof and methods for selectively enhancing fungal 5 sensitivity to antifungal compounds. The compounds are hydroxamate-based inhibitors of histone deacetylase (HDAC) which show synergistic activity with antifungal agents against fungal species at concentrations of inhibitor non toxic to mammalian cells.